Pedro Chequer, head of Brazil’s HIV/AIDS program, on Thursday told attendees at a Latin American forum — which was aimed at discussing strategies on providing access to treatments for HIV/AIDS and other sexually transmitted diseases — that countries unqualified to afford antiretrovirals should rate breaking transpacific patents and producing the drugs, the AP/Pravda.ru reports (AP/Pravda.ru, 1/13). Included the World Mercantilism Organization’s guru attribute concordat, governments can approve the indigenous production of generic versions of patented drugs during emergency public health situations if they dwindle to reach an agreement with the trade mark holder (Kaiser Daily HIV/AIDS Look into, 7/6/05). Chequer at the meeting — which took place in Brasilia, Brazil, and included representatives from 19 Latin American countries — also said countries able to yield treatment should negotiate prices with pharmaceutical companies, noting Brazil’s experience with negotiating move prices seeking HIV/AIDS drugs (AP/Pravda.ru, 1/13). In July 2005, Brazil’s health clergy and Abbott Laboratories said they had reached an agreement for Abbott to keep the government’s annual expenses on the company’s antiretroviral drug Kaletra at current levels for the next six years and Brazil not to break Abbott’s patent. Anyhow, Brazilian Haleness Minister Jose Saraiva Felipe dismissed the agreement and said the country would keep on to negotiate over the extent of a lower expenditure or nation manufacturers would overcome Abott’s patent and spark the drug in requital for 41 cents per medicament. Brazil in October 2005 reached an concurrence with Abbott to lower the expense of the company’s antiretroviral drug Kaletra from $1.17 to 63 cents per pill to protect the drug’s clear (Kaiser Daily HIV/AIDS Report, 10/12/05). Chequer at the colloquy said, “The alternative” to negotiating with pharmaceutical companies “is domestic production of the medication, preferably by the authority,” adding, “[W]e produce up to 9 times the fair price” (AP/Pravda.ru, 1/13). Chequer also voiced his support for countries that do not consent to nonscientific resistance to condom practice, such as religious or philosophical debate (Xinhuanet, 1/12).
“Reprinted with laxity from http://www.kaisernetwork.org. You can view the uninterrupted Kaiser Daily Healthiness Policy Report, search the archives, or sign up for the purpose email conveyance at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Strength Policy Report is published inasmuch as kaisernetwork.org, a free service of The Henry J. Kaiser Relatives Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Way of thinking drug information on Kaletra Capsules and Oral Solution.